Startup Circular Genomics Raises $4.5M in Seed Funding
The company was founded earlier this year to commercialize a test for depression based on circular RNA biomarker technology.
Source: 360dx.com
Stay updated with breaking news from Circular Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company was founded earlier this year to commercialize a test for depression based on circular RNA biomarker technology.
The company was founded earlier this year to commercialize a test for depression based on circular RNA biomarker technology.
UNM technology diagnoses neurological disorders, indicates best treatment for patients